Librium Tabs (Chlordiazepoxide)

Chlordiazepoxide acts as a positive allosteric modulator at the GABA‑A receptor complex. By binding to a specific benzodiazepine site, it enhances the inhibitory effect of the neurotransmitter gamma‑aminobutyric acid (GABA), increasing chloride ion influx and hyperpolarising neuronal membranes, which produces anxiolytic, sedative, muscle‑relaxant and anticonvulsant effects.

The appropriate dose of Librium Tabs is determined individually by the prescribing clinician based on the patient’s condition, age, liver function and response to therapy. Dosage may be adjusted during treatment, and any changes should be made only under medical supervision. Patients should follow the prescription label exactly.

Safety of chlordiazepoxide in pregnancy and lactation has not been established, and the drug is generally avoided unless the potential benefit outweighs the risk to the fetus or infant. It can cross the placenta and be excreted in breast milk, so clinicians usually recommend alternative therapies for pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Librium Tabs. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and assistance with import documentation.

Librium (chlordiazepoxide) is a long‑acting benzodiazepine, whereas alternatives such as diazepam or lorazepam may have intermediate or short half‑lives. Its prolonged action can provide smoother coverage for alcohol withdrawal but may also increase the risk of accumulation and daytime sedation. Choice of agent depends on the clinical scenario, patient metabolism, and the need for rapid versus sustained effect.

Librium Tabs should be stored at room temperature, below 25 °C, in the original blister or container to protect them from moisture and light. Keep the medication out of reach of children and do not use it after the expiry date printed on the packaging. Avoid storing in bathrooms or other humid environments.

Librium is taken orally, usually with a glass of water. Tablets can be swallowed whole or, if necessary, broken into halves as directed by the prescriber. The medication is typically taken once or multiple times per day depending on the indication and the dose prescribed. Patients should not crush or chew the tablets unless specifically instructed.

The most serious risks include the potential for respiratory depression, especially when combined with other central nervous system depressants, the development of physical dependence and withdrawal syndrome after prolonged use, and rare but severe reactions such as anaphylaxis, severe skin rashes, or hepatic injury. Patients should seek immediate medical attention if they experience difficulty breathing, severe rash, or sudden changes in mental status.

Librium is contraindicated in individuals with known hypersensitivity to chlordiazepoxide or any benzodiazepine, patients with acute narrow‑angle glaucoma, and those who are currently intoxicated with alcohol or other CNS depressants. Caution is also advised for patients with severe respiratory insufficiency, severe hepatic impairment, or a history of substance misuse. The drug should only be prescribed after a thorough clinical assessment by a qualified health professional.